Hirschfeld Oncology utilizes molecular profiling to direct the use of targeted therapies, such as PARP inhibitors like Olaparib, for patients with specific genetic subgroups.

Authors

• Person: Not available Organization: HOncology
  10 Breakthrough Research and Clinical Trials Shaping the ...

Sources

• 10 Breakthrough Research and Clinical Trials Shaping the ... honcology.com HOncology via serper

Referenced by nodes (4)

• Hirschfeld Oncology entity
• olaparib concept
• PARP inhibitors concept
• biomarker testing concept